Risk of cancer in children exposed to antiretroviral nucleoside analogues in utero: The french experience.

Author: , BlancheStéphane, ClavelJacqueline, DollfusCatherine, FayeAlbert, GoujonStéphanie, HleyhelMira, MandelbrotLaurent, SibiudeJeanne, TubianaRoland, WarszawskiJosiane

Paper Details 
Original Abstract of the Article :
All nucleoside analogues for treating HIV infection, due to their capacity to integrate into and alter human DNA, are experimentally genotoxic to some extent. The long-term oncogenic risk after in utero exposure remains to be determined. Cancer incidence in uninfected children exposed to nucleos(t)i...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/em.22162

データ提供:米国国立医学図書館(NLM)

In Utero Exposure to Antiretroviral Nucleoside Analogues: A Comprehensive Analysis

This research investigates the potential long-term oncogenic risk associated with in utero exposure to antiretroviral nucleoside analogues, which are crucial for managing HIV infection. The authors analyzed data from a large cohort of children born to HIV-positive mothers in France, focusing on the incidence of cancer in those exposed to nucleoside reverse transcriptase inhibitors (NRTIs) during pregnancy. The researchers found an overall cancer incidence similar to that of the general population, but a significantly higher risk for children exposed to didanosine, particularly during the first trimester.

Didanosine and Cancer Risk: A Complex Interplay

The study highlights the importance of understanding the long-term effects of in utero exposure to antiretroviral medications. The findings suggest that didanosine might pose a specific oncogenic risk, particularly during early pregnancy. This research is like exploring a complex desert ecosystem, where even subtle changes in the environment can have significant long-term impacts.

Understanding the Risks: A Journey Towards Informed Decisions

The study provides valuable insights into the potential risks associated with in utero exposure to antiretroviral nucleoside analogues. The researchers' findings emphasize the need for further research to better understand the long-term health implications of these medications, particularly for pregnant women and their children.

Dr.Camel's Conclusion

This research highlights the importance of understanding the long-term health implications of in utero exposure to antiretroviral medications, particularly nucleoside reverse transcriptase inhibitors (NRTIs). The findings suggest that didanosine might pose a specific oncogenic risk, particularly during early pregnancy, emphasizing the need for further research and careful consideration of treatment options for pregnant women living with HIV.

Date :
  1. Date Completed 2019-12-12
  2. Date Revised 2019-12-17
Further Info :

Pubmed ID

29206312

DOI: Digital Object Identifier

10.1002/em.22162

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.